Twist Bioscience (FRA:0ME) Total Stockholders Equity : €515.3 Mil (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Twist Bioscience Total Stockholders Equity?

Twist Bioscience's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €515.3 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Twist Bioscience's Book Value per Share for the quarter that ended in Mar. 2024 was €8.86. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Twist Bioscience's Debt-to-Equity for the quarter that ended in Mar. 2024 was 0.16.

Twist Bioscience Total Stockholders Equity Historical Data

The historical data trend for Twist Bioscience's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Twist Bioscience Total Stockholders Equity Chart

Twist Bioscience Annual Data

Trend

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Total Stockholders Equity

Get a 7-Day Free Trial

138.09

285.49

493.70

797.28

584.16

Twist Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Stockholders Equity	Get a 7-Day Free Trial															657.47	606.92	584.16	541.07	515.32

Twist Bioscience (FRA:0ME) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Twist Bioscience's Book Value per Share for the quarter that ended in Mar. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(515.321	-	0)	/	58.162
	=	8.86

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Twist Bioscience's Debt-to-Equity for the quarter that ended in Mar. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(13.451	+	68.82)	/	515.321
	=	0.16

Twist Bioscience Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Twist Bioscience's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Twist Bioscience (FRA:0ME) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Twist Bioscience Corp (FRA:0ME) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TWST:USA 0ME:Germany

Address

681 Gateway Boulevard, South San Francisco, CA, USA, 94080

Website

https://www.twistbioscience.com

Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of its revenue from the United States.

Twist Bioscience (FRA:0ME) Headlines

No Headlines